PLANTS, THEIR PROPERTIES, YOUR BALANCE.
Botanical photograph: Common scurvygrass (Cochlearia officinalis L.)

BOTANICAL PHOTOGRAPH · BRASSICACEAE

THE HERBARIUM · BRASSICACEAE

Common scurvygrass

Cochlearia officinalis L.

Source topics

These topics describe what the sources discuss, including unproven claims and risks. They are not therapeutic recommendations.

Documentary entry
  • Documented inventory entryInsufficient evidence
  • Research contextPreclinical research
Plant partleaf
FormsNo recommended preparation

Documentary entryReported uses only. No preparation or therapeutic use is recommended.

Documentary profile: no therapeutic use or dose is recommended here.

Identity & origin

BOTANICAL IDENTITY

The right name is the first step.

A biennial or perennial native to northern and western Europe.

Part used
leaf
Origin & distribution
Northern and western Europe.

Also known as: Cochlearia officinalis

The leaf appears in the inventory. A historical common name does not specify a dose or preparation. A photograph alone cannot certify a plant for consumption.

An illustration is not enough to identify a plant for consumption. Do not forage for a species based solely on this profile.

Uses & evidence

UNDERSTANDING THE USES

Properties & uses.

Insufficient evidence

Documented inventory entry

ANSM List A records: leaf. It inventories traditional use without specifying an indication, dose or clinical benefit here.

The references do not establish a benefit. Lack of evidence is not assurance of safety.

Read the source
Preclinical research

Research context

Plant material analysed in the laboratory. Scurvygrass notably contains cochlearine. Detecting a molecule establishes neither clinical benefit nor toxicity equivalent to jimsonweed.

Laboratory or animal observation. A human benefit cannot be inferred from this finding alone.

Read the source

The traditional uses described are not clinical proof of effectiveness. Evidence for one preparation cannot automatically be applied to another.

Precautions before use

BEFORE ANY USE

Precautions & contraindications.

This guidance does not cover every individual situation. Missing information is not a guarantee of safety.

Contraindications & precautions

  • Insufficient dataThis targeted audit does not provide a comprehensive contraindication review; this does not mean contraindications are absent.

Medicine interactions

  • Insufficient dataThis dossier cannot establish compatibility with medication. A limited study does not replace an interaction review of the exact product.
Other retained warnings · review incomplete

These existing warnings remain relevant to consult. Their exhaustive reassessment is outside this targeted review.

Restrictions and precautions

  • Avoid if allergic to this plant. The sources for this profile do not provide a complete contraindication assessment.

Medicine interactions

  • Interactions are not assessed in this profile: have any combination with medication checked.

Pregnancy, breastfeeding and children

Safety information is insufficient to recommend medicinal use during pregnancy or breastfeeding.

This profile establishes no paediatric preparation or dose.

“Reported” does not prove causality; “possible” may reflect indirect evidence. “None reported” means none in the cited source, not that all combinations have been studied. Do not stop a prescribed treatment based on this profile.

Adverse effects

  • The selected sources do not establish the frequency of adverse effects.

Pregnancy & breastfeeding

Safety information is insufficient to recommend medicinal use during pregnancy or breastfeeding.

Children & adolescents

This profile establishes no paediatric preparation or dose.

If symptoms persist, worsen or are unusual, consult a healthcare professional. In an emergency, contact the emergency services.

Available evidence

EXPLORE THE EVIDENCE

The available evidence.

The research describes chemical composition, not a treatment.

Constituents to know.

Their presence and quantity depend on the plant part and preparation.

Cochlearine
Constituent studied in this publication’s preparation.Read the reference
Preclinical research

What was measured

Nortropane alkaloids were detected through phytochemical analysis.

Laboratory or animal observation. A human benefit cannot be inferred from this finding alone.

Read the reference

Limitations to keep in mind.

This finding concerns the study preparation; it provides no home-use instructions.

Studies, findings & limitations

THE RESEARCH

What the research shows.

A laboratory or animal result alone does not demonstrate a benefit in humans. Each result must be read alongside the preparation studied and its limitations.

01Preclinical research

Brock et al. — Brassicaceae contain nortropane alkaloids (2006)

Laboratory or animal observation. A human benefit cannot be inferred from this finding alone.

Type of research
Analyses of several Cochlearia species.
Preparation concerned
Plant material analysed in the laboratory.
Observed results
Scurvygrass notably contains cochlearine.
Limitations to consider
Detecting a molecule establishes neither clinical benefit nor toxicity equivalent to jimsonweed.
Read the reference

What can we take from this?

Detecting a molecule establishes neither clinical benefit nor toxicity equivalent to jimsonweed.

Documentary review dated 09/10/2026. The references remain available to check the context.

Sources & last review

CHECKING REFERENCES

Sources for this profile.

  1. ANSM — Liste A, janvier 2026, page 12Accessed on 09/10/2026
  2. Kew POWO / MPNS — Cochlearia officinalisAccessed on 09/10/2026
  3. Brock et al. (2006). Brassicaceae contain nortropane alkaloids.Accessed on 09/10/2026

Image: Chase Mathey · CC BY 4.0. View the original image and its licence. Image resized and converted to WebP.

Looking for personal guidance?View consultations · from $40 USD
WhatsApp Appointments